We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+466.5%
AUM
$734B
AUM Growth
-$36.7B
Cap. Flow
+$3.56B
Cap. Flow %
0.48%
Top 10 Hldgs %
15.88%
Holding
8,241
New
197
Increased
3,111
Reduced
3,746
Closed
238

Sector Composition

Rank Sector Weight
1 Technology 17.71%
2 Healthcare 11.34%
3 Financials 9.38%
4 Consumer Discretionary 8.31%
5 Communication Services 5.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRIN
7301
DELISTED
Marin Software
MRIN
$1K ﹤0.01%
67
-4,846
-99% -$51.4K
QUCY
7302
Quantum Cyber N.V.
QUCY
$31.2M
$1K ﹤0.01%
+2
New +$730
NVCT icon
7303
Nuvectis Pharma
NVCT
$632M
$1K ﹤0.01%
201
+1
+0.5% +$9
OBIO icon
7304
Orchestra BioMed
OBIO
$263M
$1K ﹤0.01%
100
-557
-85% -$5.52K
PBHC icon
7305
Pathfinder Bancorp
PBHC
$102M
$1K ﹤0.01%
64
PED icon
7306
PEDEVCO
PED
$151M
$1K ﹤0.01%
50
-9,772
-99% -$218K
PET
7307
DELISTED
Wag!
PET
$1K ﹤0.01%
+328
New +$2.15K
PHIO icon
7308
Phio Pharmaceuticals
PHIO
$12.7M
$1K ﹤0.01%
14
POET icon
7309
POET Technologies
POET
$1.48B
$1K ﹤0.01%
300
+200
+200% +$815
JF
7310
J and Friends Holdings
JF
$18.5M
$1K ﹤0.01%
3,760
-400
-10% -$372
QIPT
7311
DELISTED
Quipt Home Medical
QIPT
$1K ﹤0.01%
+300
New +$1.5K
REVB icon
7312
Revelation Biosciences
REVB
$4.42M
0
RNXT icon
7313
RenovoRx
RNXT
$51.9M
$1K ﹤0.01%
428
-1,200
-74% -$2.61K
ROAM icon
7314
Hartford Multifactor Emerging Markets ETF
ROAM
$110M
$1K ﹤0.01%
80
+63
+371% +$1.24K
SANG
7315
Sangoma Technologies
SANG
$138M
$1K ﹤0.01%
200
-3,800
-95% -$29.8K
SEA icon
7316
US Global Sea to Sky Cargo ETF
SEA
$15.5M
$1K ﹤0.01%
100
SFYX
7317
DELISTED
SoFi Next 500 ETF
SFYX
$1K ﹤0.01%
114
SLDPW icon
7318
Solid Power Inc Warrant
SLDPW
$8.58M
$1K ﹤0.01%
1,370
SLNO
7319
DELISTED
Soleno Therapeutics
SLNO
$1K ﹤0.01%
+649
New +$1.58K
SMN icon
7320
ProShares UltraShort Materials
SMN
$3.77M
$1K ﹤0.01%
9
-19
-68% -$1K
SQFTW icon
7321
Presidio Property Trust Inc Series A Warrants
SQFTW
$196K
$1K ﹤0.01%
7,962
SSKN
7322
DELISTED
Strata Skin Sciences
SSKN
$1K ﹤0.01%
87
+36
+71% +$366
SYPR icon
7323
Sypris Solutions
SYPR
$48.1M
$1K ﹤0.01%
400
-1
-0.2% -$2
TARA icon
7324
Protara Therapeutics
TARA
$220M
$1K ﹤0.01%
244
-2,210
-90% -$7.49K
TMFX icon
7325
Motley Fool Next Index ETF
TMFX
$34.6M
$1K ﹤0.01%
+100
New +$1.5K

Similar funds

Morgan Stanley's Q3 2022 Portfolio in Review

As of Q3 2022, Morgan Stanley held 8,241 positions worth $734B, down 4.8% from $770B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Morgan Stanley's Q3 2022 filing shows 197 new, 3,111 increased, 3,746 reduced and 238 closed positions. Its largest new stake was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M. The largest sale was Amgen, an estimated $568M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

  • Morgan Stanley's largest Q3 2022 buy was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M.
  • Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $836M increase.
  • Morgan Stanley's biggest Q3 2022 reduction was Amgen, cutting an estimated $568M.
  • Morgan Stanley fully exited Coherent Inc in Q3 2022, selling an estimated $104M.
  • Morgan Stanley's ten largest holdings make up 16% of its $734B portfolio in Q3 2022.
  • Morgan Stanley opened 197 new positions and closed 238 in Q3 2022.
  • Morgan Stanley's portfolio value fell 4.8% quarter-over-quarter to $734B.

Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.